Viewing nowFloga 10 mg (Dapagliflozin Propanediol Monohydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Nexpharm Korea Co., Ltd.

MFDS item code 202300285 · Approved 2023.01.17 · Insurance code 662504840
Treatment of type 2 diabetes, chronic kidney disease, and chronic heart failure
This medication is used as an adjunct to diet and exercise to help control blood sugar in patients with type 2 diabetes. It is also administered in combination with other standard treatments in patients with chronic heart failure to reduce the risk of death and hospitalization due to cardiovascular disease. Additionally, it is given to patients with chronic kidney disease to help lower the risk of decreased kidney function and death caused by cardiovascular disease. Thus, this medication improves the treatment and management of diabetes, cardiovascular, and kidney-related diseases.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy When administered in combination with metformin to patients who have not previously received pharmacological treatment for diabetes, the recommended initial dose of this medicine is 5 mg once daily or 10 mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this medicine to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of treatment with this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in patients who are allergic to the active ingredients or additives of this drug. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with lactose intolerance or certain genetic metabolic disorders should not use this medication due to the lactose content. This medication should not be administered to patients undergoing dialysis. Patients with reduced fluid volume or renal dysfunction should use this medication with caution and should regularly check their kidney function and fluid status. Particularly in elderly patients or those on diuretics, and in patients with reduced renal function, careful management is necessary as the risk of hypotension or kidney damage may be increased. The blood sugar control effect of this drug may vary according to kidney function, and it is not recommended for patients with significantly reduced kidney function. During treatment with this medication, genital infections and urinary tract infections may occur, so immediate treatment should be sought if symptoms of infection appear. There is a risk of hypoglycemia, so close observation for hypoglycemic symptoms is necessary when used in combination with medications such as insulin or sulfonylureas. Dehydration or hypotension symptoms may occur due to reduced fluid volume, so adequate hydration and consultation with a physician in case of symptom occurrence are required. Serious metabolic disturbances like diabetic ketoacidosis may occur, so if symptoms such as vomiting, abdominal pain, or breathing difficulties are present, notify medical personnel immediately. Women who are pregnant or nursing should preferably not use this medication; if pregnancy is confirmed, treatment should be discontinued. The safety and efficacy of this medication have not been sufficiently established for children, so it should not be used in pediatric patients. In case of an overdose, there is no specific antidote, and appropriate treatment should be administered according to the symptoms, following the physician's directions. This medication does not significantly affect the ability to drive or operate machinery, but caution is necessary in the case of hypoglycemia.
vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, polydipsia, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, elevated hematocrit, initial treatment decrease in renal creatinine clearance, dyslipidemia, initial treatment increase in blood creatinine, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral arterial occlusion, angina pectoris, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, paresthesia, cerebral infarction, nerve compression, urosepsis, acute kidney injury, renal dysfunction, chest pain, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like syndrome, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, excessive sweating eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweat, flank pain, fibromyalgia, limb discomfort, muscle cramps, musculoskeletal discomfort, osteopenia, muscular weakness, contusion, traffic accident, drug overdose, ankle fracture, orbital fracture, foot fracture, gastrointestinal foreign body, hand fracture, iliac fracture, laceration, ligament rupture, limb injury, meniscus injury, skin abrasion, tendon rupture, thoracic vertebra fracture, tibia fracture, dental injury, dry eye, eye pain, retinal disorders, decreased vision, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, glaucoma, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorder, epistaxis, sputum, sleep apnea syndrome, wheezing, atherosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, palpitations, anxiety disorder, nocturia, hallucinations, sleep disorders, insomnia, fatty liver, gallbladder polyp, vertigo, tinnitus, anal-genital warts, adenomatous polyp, neuroma, unspecified pituitary neoplasm, male hypogonadism, thyroid cyst, thyroid nodule, food allergy, polycythemia, dyspepsia, nausea, diarrhea, vomiting, urinary retention, abnormal urination, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased appetite, asthenia, headache, nasopharyngitis, upper respiratory infection, chest discomfort, vaginal discharge, itching, arthralgia, musculoskeletal pain, limb pain, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to protect it from air and moisture. It is best to keep the medication at room temperature between 1°C and 30°C, avoiding excessively cold or hot places.
Yellow, double convex, diamond-shaped film-coated tablet
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle, Box - 28 tablets/box[((7 tablets/Alu-Alu)x4)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Nexpharm Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.